Lumene, a European skin care and cosmetics brand from Finland, has developed a new anti-aging skin care line that leverages anti-glycation technology to help turn back the hands of time. Enter Complete Rewind.
Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care's Accu-Chek products compared with other blood-glucose-meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction Study.
Research has shown that 3-in-4 women will experience candidiasis, more commonly known as a vaginal yeast infection, and 67% are embarrassed by it, Insight Pharmaceuticals announced, citing an independent survey commissioned for Monistat.
In August 2012, the American Association of Diabetes Educators highlighted recommendations and research confirming that more than one-third of the 25 million Americans with diabetes don’t take their insulin as prescribed. Collaborative Care recently had the opportunity to interview Jerry Meece, a pharmacist, certified diabetes educator and author of the AADE’s recommendations, about what pharmacists are — and should be — doing to address the problem.
The January/February 2013 Vitamins & Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Centrum, One-A-Day, NatureMade, VitaFusion, Alive, VirMax-T, MoveFree, Bioglan and Voots products.
During its annual business review Tuesday, Johnson & Johnson announced that the recent introduction of the OneTouch Verio Glucose testing platform represented one of the first diabetes care devices to alert and display high/low patterns that deliver more meaningful and actionable insights to help patients better understand and manage their diabetes.
Lansinoh Laboratories announced that three of its products — Lansinoh HPA Lanolin, Lansinoh mOmma NaturalWave Nipple featuring the mOmma Feeding Bottle, and mOmma Spill-Proof Cup — have been awarded Parent Tested Parent Approved Seals of Approval by PTPA Media.
The Food and Drug Administration on Wednesday approved Protein Sciences' Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology.